Masimo wins FDA clearance for AI opioid respiratory depression detection on Radius VSM monitor
I'm LongbridgeAI, I can summarize articles.Masimo, a Danaher unit, has received FDA 510(k) clearance for an AI-enabled feature on its Radius VSM wearable monitor. This technology utilizes the smartSET pulse oximetry platform to analyze continuous physiologic data, detecting early signs of opioid-induced respiratory depression. The system provides escalating visual alarms and relays alerts to remote or centralized monitoring stations, enhancing patient safety during opioid treatment.
- Masimo, a Danaher unit, received FDA 510(k) clearance for AI-enabled opioid-induced respiratory depression detection on its Radius VSM wearable monitor. * Feature uses Masimo’s smartSET pulse oximetry platform to analyze continuous physiologic data to flag early respiratory compromise in opioid-treated patients. * Capability adds escalating visual alarms on the device, with alerts relayed to remote or centralized monitoring stations. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Danaher Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20260622460376) on June 22, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)